Hide Board Information

Show Board Information

Theriva Biologics, Inc. TOVX

Board Mod: Add me as mod

Asst Mods:

Last Post: 09/27/2022 12:20:51 PM

Board Marks: 3

Posts Today: 0

Board Views Today: 19

Theriva Biologics, Inc. (NYSE: TOVX) Stock Message Board

1. TOVX Company Profile

    

2. TOVX Time & Sales

    

3. TOVX Recent News

    

4. TOVX Filings

    

5. TOVX Financials

    

6. TOVX Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	SYN 1.69 Synthetic Biologics Inc Stock Charts	chartguy89	11/25/2014 8:19:01 AM
6	$SYN brea	PoemStone	08/20/2014 2:00:53 PM
5	You're here too? Boogity	BooDog	05/15/2014 3:31:06 PM
4	$SYN $2.70	PoemStone	04/21/2014 11:54:43 AM
3	Hey, another SYNNER here! I'm on board, been	Ann1	03/13/2014 12:38:11 AM
2	$SYN a rising flag $2.89 from 12/10/13 $1.23	PoemStone	03/12/2014 5:35:58 PM
1	$SYN $1.23 on the bottom PR Shares Outstanding	PoemStone	12/10/2013 7:16:21 AM

Newer

Recent Articles

• Magnite Challenges Google's Monopoly in U.S. Courtroom Battle
• TRIMEDX Achieves Recognition as a Global Inspiring Workplace
• Revolutionary AirJoule System Enhances Water Solutions in Texas
• Strata Critical Medical Expands with Keystone Perfusion Deal
• Flux Power Secures $5 Million in Innovative Financing Deal
• Body Vision Medical Expands Access to Lung Cancer Imaging Solutions
• iQSTEL Aims for Major Financial Milestone by 2026
• Reborn Coffee Launches New Logistics Subsidiary to Optimize Growth
• Innovative Dealer Calculator Launch by Fasten Enhances Loyalty
• Worthington Enterprises Highlights Sustainability Efforts in 2025 Report
• Shimmick Corporation Wins Major Infrastructure Contracts
• Eco Warriors Series: Monarch Butterflies' Journey in New Book
• Flux Power Secures $5 Million in Strategic Funding Round
• Miata Metals Unveils Promising Gold Drill Results at Sela Creek
• RxSight, Inc. Engages in Class Action Amid Stock Volatility
• Highlights from the 2025 A.I. Awards Finalists Announcement
• AvePoint's Public Offering: Key Insights and Market Strategy
• Lineage, Inc. Faces Lawsuit Amid Significant Stock Price Decline
• TerraMaster F4-425 NAS: A Leap Forward in Home Storage
• Charter Communications Faces Legal Action Resulting from Stock Decline
• Miguel Rangel's Vision as CEO of Allura USA and Elementia USA
• Kelyniam Global Inc. Prepares for Life Sciences Investor Forum
• Couple Takes Charge of New PostalAnnex Venture as Franchisees
• Metallium and Ucore Collaborate to Revolutionize Rare Earth Element Industry
• Tom Lee Sees Potential for Major Bitcoin and Ethereum Surge
• Solutions II Expands Reach with Acquisition of Vertical VAR
• Gold Prices Set to Soar Even Higher: What Investors Should Know
• The Impact of Piracy on the Streaming Revenue Landscape
• Insights on Recent Trades: Uber, Apollo, and FTAI Aviation
• Advancements in Optical Signal Filtering with Fiber Bragg Gratings
• Bridge Legal Joins ILFA to Enhance Access to Justice Initiatives
• City of London Investment Group Delivers Impressive Results
• Loulou Lollipop Launches Exciting New Baby Products at Retail
• Transform Your Business Online Instantly with GoDaddy Airo
• Celebrating New Horizons for Family Well-Being Support
• Explore the New Snuggle Me Nursing Cover and Crib Sheets
• Discover the Rich Flavors of Canaan Palestine's Za'atar Spice
• Shelpful Unveils Innovative ADHD-Focused Chat App for Tasks
• Exploring Financial Support in Long-Term Care Planning
• WConnect: Pioneering a Unified Web3 Ecosystem for Growth
• Introducing the Powerful 2026 Mercedes-Benz AMG GLE 53 SUV
• The Ether Machine's Path to Public Trading and Growth Ahead
• Gotion High-Tech Partners with ACWA Power for Major Solar Project
• GraniteShares Unveils Innovative YieldBOOST ETFs for Investors
• ABB Commits $110 Million to Expand US Manufacturing Operations
• AltrixBio Strengthens Leadership with $5 Million Funding Boost
• Introducing the Low-Profile A-361 Nanopositioning Stage
• Orion Energy Systems Lands $11 Million in Sustainability Projects
• Paladin Energy's A$300 Million Success and Future Plans
• Myrtelle's Revolutionary Gene Therapy Brings Hope for Canavan